United States & United States — Biomedical Advanced Research and Development Authority

United States: The United States>>> has pledged financial aid and is monitoring the Ebola outbreak, with some of its citizens exposed or infected, but its previous aid cuts and withdrawal from the World Health Organization>>> have been criticized for weakening global health response capacity.

United States — Biomedical Advanced Research and Development Authority: The United States — Biomedical Advanced Research and Development Authority has backed the development of MBP134 and is coordinating shipments of the investigational treatment for potential use in high-risk Americans.

United States: U.S. government agency BARDA provided funding; event highlights U.S. investment in antifungal R&D.

United States — Biomedical Advanced Research and Development Authority: BARDA awarded additional funding to Basilea under an existing OTA, supporting development of novel antifungal agents.

United States: The U.S. gains a new flu vaccine option, potentially improving public health outcomes for older adults.

United States — Biomedical Advanced Research and Development Authority: BARDA's mRNA vaccine development activities were wound down by HHS, reducing federal support for mRNA technology. This approval may partially offset that setback.

United States: The United States>>> government, through its agency United States — Biomedical Advanced Research and Development Authority>>>, is providing significant funding for the development of a new antibiotic to address public health concerns.

United States — Biomedical Advanced Research and Development Authority: The United States — Biomedical Advanced Research and Development Authority>>> awarded USD 13.3 million to Basilea Pharmaceutica>>> to support the development of a novel antibiotic, demonstrating its commitment to addressing public health needs related to multidrug-resistant infections.